HRMY CIK: 1802665

Harmony Biosciences Holdings, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
98.6
FY22:
144
FY23:
219
FY24:
220
FY25:
348
Change from FY21 to FY25
millions USD
FY21:
−100
FY22:
−142
FY23:
−46.4
FY24:
−67.5
FY25:
−39.6
Change from FY21 to FY25
millions USD
FY21:
7.42
FY22:
6.84
FY23:
−106
FY24:
−11.0
FY25:
−9.05
millions USD
FY21:
5.68
FY22:
9.48
FY23:
67.4
FY24:
141
FY25:
300
(positive)
Change from FY21 to FY25
millions USD
FY21:
98.3
FY22:
144
FY23:
219
FY24:
219
FY25:
348

All amounts in millions USD Data source:SEC EDGAR